344Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
Spain
Neuroscience Intelligence
Spain neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #8 of 50 · Data maturity A · Research score 48.7 · Data confidence 100.0 / 100 · Snapshot 2026-10-12 03:34 UTC.
93Recruiting trials
303Publications
284Institutions
Executive interpretation
Spain ranks #8 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
Merck Sharp & Dohme LLC2212 recruiting
Hoffmann-La Roche176 recruiting
Hospital Universitari Vall d'Hebron Research Institute80 recruiting
UCB Pharma80 recruiting
University of Valencia72 recruiting
Pfizer71 recruiting
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau63 recruiting
Eli Lilly and Company60 recruiting
Eisai Inc.64 recruiting
Cardenal Herrera University53 recruiting
Disease activity
Parkinsons64trials
Alzheimers50trials
Epilepsy34trials
Pain Neuropathy17trials
Depression16trials
Stroke15trials
Neuromuscular14trials
Other Neurology13trials
Multiple Sclerosis12trials
Autism10trials
Research institutions
Hospital Universitario de La PrincesaOpenAlexlinked institution
Hospital de GaldakaoOpenAlexlinked institution
Institut de Recerca en Energia de CatalunyaOpenAlexlinked institution
Universidad de AlcaláOpenAlexlinked institution
Universidad de JaénOpenAlexlinked institution
Institut Universitari d'Investigació en Atenció Primària Jordi GolOpenAlexlinked institution
Agència de Qualitat i Avaluació Sanitàries de CatalunyaOpenAlexlinked institution
Universidad San Pablo CEUOpenAlexlinked institution
University Hospital HM Puerta del SurOpenAlexlinked institution
Sociedad Española de CardiologíaOpenAlexlinked institution
Clinical evidence trail
NCT07842926Acute Effects of Capacitive-Resistive Radiofrequency Therapy in People With Parkinson's DiseaseRECRUITING
NCT07798674TreatHSP Platform: Adaptive Natural History Platform for Ataxias, HSPs, and Spastic AtaxiasRECRUITING
NCT07730671PENSA+: Extended Follow-up of a Multimodal Lifestyle Intervention to Prevent Cognitive Decline in APOE-ε4 CarriersNOT_YET_RECRUITING
NCT07654114Safety, Tolerability, and Preliminary Effectiveness of CTH120 in Fragile X SyndromeRECRUITING
NCT07567261Efficacy and Safety of Repetitive Transcranial Magnetic Stimulation and Expressive Writing for Post-Traumatic StressNOT_YET_RECRUITING
NCT07282704Falls In Spanish People With Intellectual Disabilities: Risk Factors And Predictive Equation. Falls.Di StudyRECRUITING
Research evidence trail
PUBMEDThe role of physiotherapists in acute post-stroke neurorehabilitation: qualitative perspectives from clinicians and stroke unit managers.2026-12-31
PUBMEDLatent Space Projections and Atlases, a Cautionary Tale in Deep Neuroimaging using Autoencoders.2026-12-30
PUBMEDSymptom networks in manic and mixed presentations of bipolar disorder: Mapping the crossroads.2026-12-15
PUBMEDPlasma endocannabinoid levels in bipolar disorder: Differences between manic and euthymic states and the impact of cannabis use.2026-12-15
PUBMEDIn their own words: A qualitative focus group study of resilience in bipolar disorder.2026-12-15
PUBMEDStructured management of dopamine agonist withdrawal in restless legs syndrome with augmentation: A prospective real-world cohort study.2026-12-01
PUBMEDCognitive profiles in first-episode psychosis: The impact of genetics, environment, and cognitive reserve as risk and protective factors.2026-12-01
PUBMEDAttentionally directed oculomotor training produces disease-stage-dependent effects on plasma tau, cognition, and oculomotor signatures in patients with mild cognitive impairment.2026-12-01
PUBMEDDifferences across males and females in cognitive aging and mortality risk: a trajectory-based approach.2026-12-01
PUBMEDFrom options to decisions: an innovative model for treatment sequencing in relapsing-remitting multiple sclerosis.2026-12-01
PUBMEDSulcal pits analysis implicates the left inferior frontal cortex as a neurodevelopmental marker for negative symptoms in schizophrenia.2026-12-01
PUBMEDEndocannabinoid plasma concentrations and their relationship with clinical outcome and cannabis use in antipsychotic-naïve first episode psychosis.2026-12-01
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.